Otonomy Announces Proposed Public Offering of Common Stock

Back to Jobs

SAN DIEGO , Jan. 05, 2016 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that it has commenced an underwritten public offering of

Apply Now